Eli Lilly Named Gilead Favorite at BofA Ahead of Q3 Earnings
in focus Heading into the biopharmaceutical sector's third-quarter earnings season, Bank of America has taken a bullish stance on Eli ...
Tag: Lilly
Eli Lilly, Novo to lead weight loss drug market: JPMorgan
Fotolia/iStock via Getty Images JPMorgan recently raised its projections for weight loss drugs, expecting the drug category known as GLP-1 ...
Wells Fargo upgrades Amgen and Eli Lilly to Overweight, downgrades Merck to Equal Weight By Investing.com
© Reuters. Amgen & Eli Lilly upgraded to Overweight at Wells Fargo, Merck downgraded to Equal Weight Wells Fargo upgraded ...
Eli Lilly beats fourth-quarter earnings forecast, raises 2023 outlook, on Trulicity’s strength
"Over the course of this critical year, we expect to launch up to four new drugs for challenging diseases, while ...
Pfizer, AbbVie, GSK, Eli Lilly among drugmakers to raise prices (NYSE:PFE)
Sorry Pharmaceutical companies started 2023 strong, raising prices for about 450 drugs this month, with more price hikes expected, according ...
Recommended.
